Conference Proceedings
View Meeting Video
Download Syllabus
Friday, November 11, 2022
7:00 am - 6:00 pm EST
In Person at
The Rittenhouse Hotel
210 W Rittenhouse Square
Philadelphia, PA 19103
or
Virtually via AJI Media Livecast powered by Accelevents
Check In
In Person: Check in, Visit Exhibits and Continental Breakfast
Virtual: Login to Virtual Conference - Visit Virtual Exhibit Hall
Welcome and Introductions
Sunil Singhal, MD // Thoracic Surgery // Perelman School of Medicine at the University of Pennsylvania / Penn Medicine
John Y.K. Lee, MD, MSCE // Neurosurgery // Perelman School of Medicine at the University of Pennsylvania / Penn Medicine
Edward J. (Jim) Delikatny, PhD // Radiology/Optical Bioluminescence // Perelman School of Medicine at the University of Pennsylvania / Penn Medicine
Robert H. Vonderheide, MD, DPhil // Abramson Cancer Center // Perelman School of Medicine at the University of Pennsylvania / Penn Medicine
Daniel Yoshor, MD // Neurosurgery // Perelman School of Medicine at the University of Pennsylvania / Penn Medicine
D. Gregory Farwell, MD, FACS // Otorhinolaryngology – Head and Neck Surgery // Perelman School of Medicine at the University of Pennsylvania / Penn Medicine
SESSION 1 CLINICALLY APPROVED AND PHASE III TRIALS
Moderators: Eric R. Henderson, MD // Adult and Pediatric Orthopedics // Geisel School of Medicine, Dartmouth / Dartmouth Health
David E. Holt, BVSc // Surgery // University of Pennsylvania School of Veterinary Medicine
5-ALA in EUROPE – FUTURE STEPS
Walter Stummer, MD, PhD // Neurosurgery // Münster University Hospital
PAFOLACIANINE for Ovarian Cancer
Janos L. Tanyi, MD, PhD // Gynecologic Oncology // Perelman School of Medicine at the University of Pennsylvania / Penn Medicine
PAFOLACIANINE for Lung Cancer: Phase 3 US Trial
Linda W. Martin, MD, MPH // Thoracic Surgery // University of Virginia School of Medicine
CEA Colon Cancer Trial: Phase 3 European Trial
Alexander L. Vahrmeijer, MD // Oncologic Surgery // Leiden University Medical Center
Protease Activated Dye in Breast Cancer Surgery: Phase 3 US Trial
Barbara L. Smith, MD, PhD // Breast Surgery // Harvard Medical School / Massachusetts General Hospital
Q&A Panel Discussion
Break and Visit Exhibits
SESSION 2 PHASE II CLINICAL TRIALS
Moderator: Karthik Rajasekaran, MD, FACS // Head and Neck Oncologic & Microvascular Reconstructive Surgery // Perelman School of Medicine at the University of Pennsylvania / Penn MedicineAnti-EGFR Antibody Imaging Strategies for Real-Time Surgical and Pathologic Guidance
Eben Rosenthal, MD // Otolaryngology - Head & Neck Surgery // Vanderbilt University Medical Center
Phase II Trial of Intraoperative Molecular Imaging of Lung Cancer with Cathepsin Imaging
Sunil Singhal, MD // Thoracic Surgery // Perelman School of Medicine at the University of Pennsylvania / Penn Medicine
pH Sensitive Dyes in Peritoneal Surface Malignancy
Patrick Wagner, MD, FACS // Surgical Oncology // Allegheny Health Network (AHN) Cancer Institute
pH Sensitive Dyes in Phase II Lung Cancer Trial
David C. Rice, MB, BCh, FRCSI // Thoracic Surgery // M.D. Anderson Cancer Center // Houston, Texas
Q&A Panel Discussion
SESSION 3: PEDIATRIC HOUR
Moderators: Tracy Ma Flanders, MD, MSCE // Pediatric Neurosurgery // Children's Hospital of Philadelphia
Andrew M. Davidoff, MD // Pediatric Surgery // St. Jude Children's Research Hospital
Tumor Paint™ Imaging – Pediatric Brain Tumors – PHASE TWO
Amy Lee, MD // Pediatric Neurosurgery // University of Washington / Seattle Children’s Hospital
Clinical Experience Using ICG
Abdelhafeez H. Abdelhafeez, MD // Pediatric Surgery // St. Jude Children's Research Hospital
Pre-Clinical Experience on Targeted Agents for Pediatric Solid Tumors
Marcus M. Malek, MD, FAAP // Pediatric Surgical Oncology // University of Pittsburgh / UPMC
Q&A Panel Discussion
Lunch and Visit Exhibits
Session 4: PILOT AND PHASE I CLINICAL TRIALS
Moderator: Andrew Tsourkas, PhD // Bioengineering //| Perelman School of Medicine at the University of Pennsylvania / Penn Medicine
EGFR Affibody: Design & Implementation of Novel Targeted Tumor Dye
Eric R. Henderson, MD // Adult and Pediatric Orthopedics // Geisel School of Medicine, Dartmouth / Dartmouth Health
uPAR-targeting Dye (Fluoguide) for Surgery of Gliomas
Jane Skjoth-Rasmussen, MD, PhD // Adult and Pediatric Neurosurgery // Rigshospitalet / Copenhagen University Hospital / University of Copenhagen
TumorGlow™ Second Window ICG in Brain Tumors
John Y.K. Lee MD, MSCE // Neurosurgery // Perelman School of Medicine at the University of Pennsylvania / Penn Medicine
Q&A Panel Discussion
SESSION 5: NORMAL TISSUE DYES
Moderators: E. James Petersson, PhD // Chemistry // Perelman School of Medicine at the University of Pennsylvania / Penn MedicineSofya A. Osharovich, PhD // Pharmacology // Perelman School of Medicine at the University of Pennsylvania / Penn Medicine
Nerve Specific Dyes – Normal Tissue Identification
Ryan K. Orosco, MD // Otolaryngology // University of New Mexico
Near Infrared Nerve-Specific Probes for Intraoperative Nerve Visualization
Summer L. Gibbs, PhD // Biomedical Engineering // Oregon Health & Science University (OSHU) School of Medicine / OSHU Knight Cancer Institute
Ureter Dyes During Urologic Cancer Surgery – Normal Tissue Identification
Richard W. Farnam, MD // Gynecology // Las Palmas Del Sol Healthcare
Q&A Panel Discussion
Session 6: HOW TO GET FROM BENCH TO BEDSIDE
Moderator: Mark Anthony Sellmyer, MD, PhD // Radiology // Perelman School of Medicine at the University of Pennsylvania / Penn Medicine